7,5 %Six-month mortality among HIV-infected patients in Central Kenya was 7.5% in 2004 and reduced to 3.8% in 2014.
KenyaVIH/sidaobservé 2004 to 2014publié 2021BMC infectious diseasesPubMeddocument de 10 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 68 / 90
7,5 %Six-month mortality among HIV-infected patients in Central Kenya was 7.5% in 2004 and reduced to 3.8% in 2014.
KenyaVIH/sidaobservé 2004 to 2014publié 2021BMC infectious diseasesPubMeddocument de 10 observations
90 %Of 1910 female index clients who tested positive for HIV, 1724 (90%) received assisted partner services.
KenyaVIH/sidaobservé May 1, 2018 to March 31, 2020publié 2023The Lancet. Global healthPubMeddocument de 11 observations
60 %Among 4805 women living with HIV in Kenya, 60% reported receiving family planning counseling during the last year.
KenyaVIH/sidaobservé 2016publié 2021ContraceptionPubMeddocument de 2 observations
9,6 yearsThe mean time from HIV diagnosis to enrollment was 9.6 years (SD 3.9 years) among women living with HIV in Kenya.
KenyaVIH/sidapublié 2021International journal of STD & AIDSPubMeddocument de 5 observations
32 %A total of 46 [32%] of the sexual partners elicited and traced tested HIV positive.
KenyaVIH/sidaobservé January 2017 to August 2018publié 2020BMC infectious diseasesPubMeddocument de 6 observations
35,1 %Among children and adolescents living with HIV in central Kenya, 35.1% were enrolled at WHO stage III disease.
KenyaVIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations
37 %Among 187 participants with second-line viral failure, triple-class resistance prevalence was 37%.
KenyaVIH/sidaobservé 2011 to 2021publié 2025Journal of the International AIDS SocietyPubMeddocument de 15 observations
69 %Among 120 newly diagnosed HIV-positive sex partners, 69% (83) linked to care at 6 weeks.
KenyaVIH/sidapublié 2020Sexually transmitted diseasesPubMeddocument de 4 observations
1,17 aHRIn multivariable regression model, 'test and treat' had no significant effect on risk of poor outcomes (adjusted hazard ratio = 1.17, 95%CI 0.89–1.54).
KenyaVIH/sidapublié 2022PloS onePubMeddocument de 15 observations
71 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 71 % en 2013.
KenyaVIH/sidaobservé 2013HAL · Unilimdocument de 747 observations
1,17 aHRAmong sexual contacts of HIV-positive index clients in Siaya County, Kenya, single contacts had an adjusted hazard ratio of 1.17 for HIV testing compared to married monogamous contacts.
KenyaVIH/sidaobservé June 2017-August 2018publié 2020PloS onePubMeddocument de 8 observations
1,2 %Viral load monitoring reduced maternal deaths by 1.2–1.8% in newly positive women in Kenya.
KenyaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 6 observations
76 %The prevalence of intimate partner violence (IPV) by the current partner was 76% among 408 HIV-positive women receiving free antiretroviral therapy in government health facilities in sub-Saharan Africa.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 6 observations
101 infantsAmong 187 mother-infant pairs with postpartum data, 101 (54%) infants were HIV-unexposed, uninfected (CHUU).
KenyaVIH/sidapublié 2025BMJ global healthPubMeddocument de 10 observations
37,1 %Of the 480 widowed women, 178 (37.1%) had HIV.
KenyaVIH/sidapublié 2026Global health actioneurope_pmcdocument de 5 observations
3,5 yearsChildren with HIV initiated antiretroviral therapy at a median age of 3.5 years in the late ART group.
KenyaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 10 observations
81 %Among 3,968 patients on antiretroviral treatment in Kenya who had been on ART for at least 18 months and were aged ≥18 years, 81% were virally suppressed at 18 months post-ART initiation.
KenyaVIH/sidapublié 2022PloS onePubMed
17 yearsAmong 1904 adolescents and young adults with HIV in Western Kenya, the median age was 17 years with an interquartile range of 14–19 years.
KenyaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 5 observations
3 casesThree infants out of 626 enrolled were identified as HIV-positive.
KenyaVIH/sidapublié 2020PloS onePubMeddocument de 13 observations
39 %Among 97 children with HIV on isoniazid preventive therapy, 39% had biomarker-confirmed adherence.
KenyaVIH/sidaobservé 2019 through 2020publié 2024AIDS (London, England)PubMeddocument de 5 observations
38 countAmong 92 PWID who initiated HCV treatment, 38 (41%) were HIV-positive.
KenyaVIH/sidapublié 2023The International journal on drug policyPubMeddocument de 7 observations
299 798 individualsDuring the study period from February 2017 to December 2019, 299,798 individuals tested HIV negative.
KenyaVIH/sidaobservé February 2017 to December 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 13 observations
1 per_100_person-yearsHIV incidence was 1.0 per 100 person-years in the comparison group.
KenyaVIH/sidapublié 2021The lancet. HIVPubMeddocument de 5 observations
34 %Approximately 34% of the 497 HIV-positive women disclosed their HIV-positive status to a sexual partner.
KenyaVIH/sidaobservé 2012publié 2019Journal of HIV and AIDSeurope_pmcdocument de 2 observationsDOI 10.16966/2380-5536.166
93 %Among 1,047,406 people reported with TB in Kenya between 2008 and 2018, 93% knew their HIV status.
Kenyatuberculose · VIH/sidaobservé 2008 to 2018publié 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument de 8 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.